Skip to content Search the desk⌘ Ctrl K Agent Sign in T Treace Medical Concepts, Inc.
T TMCI Treace Medical Concepts, Inc.
T TMCI Treace Medical Concepts, Inc.
Earnings When Treace Medical Concepts, Inc. reports, what it reported each quarter, and how the stock took the results.
27 quarters. Mar 31, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Feb 26, before the open
Fri, Feb 26, 2027 in 99 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Feb 24 – Mar 11 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Gross profit Operating income Operating cash flow Free cash flow
Q3 2026 $ 4 8 . 2 5 M $48.25M −3.9% vs Q3 2025
Revenue $48.25M −3.9%
Net income -$12.57M N/M
EPS -$0.19 N/M Q2 2026 Aug 7, 2026, before the openTreace Medical Concepts, Inc. · CIK 1630627 · Engraved from SEC EDGAR
Revenue $45.38M −4.2%
Net income -$15.87M N/M
EPS -$0.24 N/M
Revenue $47.20M −10.2%
Net income -$17.96M N/M
EPS -$0.28 N/M
Revenue $62.52M −9.0%
Net income -$9.39M N/M
EPS — —
Results day Typical move ±8.1% A typical move of 8.1% either way
Up after 5 of 12, down after 7.
+0.7% −39.7% −2.4%
When it reports
Usual day Varies
After quarter end 37 to 58 days
10-Q filed 37 to 38 days over its last 8
10-K filed 58 to 67 days over its last 5 ended Sep 30, 2024 · filed Nov 5, 2024 · 36 d ended Dec 31, 2024 · filed Feb 27, 2025 · 58 d ended Mar 31, 2025 · filed May 8, 2025 · 38 d ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d ended Dec 31, 2025 · filed Feb 27, 2026 · 58 d FY 2026 Q3 2026 Sep 30, 2026 Nov 6, 2026 · pre-market Nov 6, 2026 37 d 10-Q $48.25M −3.9% -$0.19 3.8% Q2 2026 Jun 30, 2026 Aug 7, 2026 · pre-market Aug 7, 2026 38 d 10-Q $45.38M −4.2% -$0.24 +8.2% Q1 2026 Mar 31, 2026 May 8, 2026 · pre-market May 8, 2026 38 d 10-Q $47.20M −10.2% -$0.28 +3.6%
FY 2025 Q4 2025 derived Dec 31, 2025 Feb 27, 2026 · pre-market Feb 27, 2026 58 d 10-K $62.52M −9.0% — 11.0% Q3 2025 Sep 30, 2025 Nov 6, 2025 · after-hours Nov 6, 2025 37 d 10-Q $50.21M +11.4% -$0.26 28.5% Q2 2025 Jun 30, 2025 Aug 7, 2025 · after-hours Aug 7, 2025 38 d 10-Q $47.39M +6.6% -$0.28 +8.1% Q1 2025 Mar 31, 2025 May 8, 2025 · after-hours May 8, 2025 38 d 10-Q $52.57M +2.9% -$0.25 9.2%
FY 2024 Q4 2024 derived Dec 31, 2024 Feb 27, 2025 · after-hours Feb 27, 2025 58 d 10-K $68.71M +10.4% — 2.1% Q3 2024 Sep 30, 2024 Nov 5, 2024 · after-hours Nov 5, 2024 36 d 10-Q $45.09M +10.6% -$0.25 +35.1% Q2 2024 Jun 30, 2024 Aug 6, 2024 · after-hours Aug 6, 2024 37 d 10-Q $44.46M +6.0% -$0.34 2.4% Q1 2024 Mar 31, 2024 May 7, 2024 · after-hours May 7, 2024 37 d 10-Q $51.11M +21.1% -$0.30 —
FY 2023 Q4 2023 derived Dec 31, 2023 Feb 27, 2024 · after-hours Feb 27, 2024 58 d 10-K $62.21M +25.0% — — Q3 2023 Sep 30, 2023 Nov 9, 2023 · after-hours Nov 9, 2023 40 d 10-Q $40.76M +23.3% -$0.28 39.7% Q2 2023 Jun 30, 2023 Aug 8, 2023 · after-hours Aug 9, 2023 40 d 10-Q $41.95M +40.0% -$0.20 — Q1 2023 Mar 31, 2023 May 8, 2023 · after-hours May 9, 2023 39 d 10-Q $42.20M +45.3% -$0.23 +0.7%
FY 2022 Q4 2022 derived Dec 31, 2022 Mar 7, 2023 · after-hours Mar 8, 2023 67 d 10-K $49.77M +48.8% — — Q3 2022 Sep 30, 2022 Nov 8, 2022 · after-hours Nov 9, 2022 40 d 10-Q $33.06M +52.9% -$0.22 — Q2 2022 Jun 30, 2022 Aug 9, 2022 · after-hours Aug 10, 2022 41 d 10-Q $29.97M +45.1% -$0.31 0.6% Q1 2022 Mar 31, 2022 May 5, 2022 · after-hours May 6, 2022 36 d 10-Q $29.05M +55.3% -$0.16 14.4%
FY 2021 Q4 2021 derived Dec 31, 2021 Mar 3, 2022 · after-hours Mar 4, 2022 63 d 10-K $33.44M +38.7% — +0.3% Q3 2021 Sep 30, 2021 Nov 4, 2021 · after-hours Nov 4, 2021 35 d 10-Q $21.62M +51.5% -$0.12 — Q2 2021 Jun 30, 2021 Aug 5, 2021 · after-hours Aug 5, 2021 36 d 10-Q $20.65M +166.9% -$0.10 6.9% Q1 2021 Mar 31, 2021 May 25, 2021 · after-hours May 25, 2021 55 d 10-Q $18.71M +66.2% -$0.07 —
FY 2020 Q4 2020 derived Dec 31, 2020 — — — — $24.10M — — — Q3 2020 Sep 30, 2020 — — — — $14.27M — -$0.08 — Q2 2020 Jun 30, 2020 — — — — $7.74M — -$0.06 — Q1 2020 Mar 31, 2020 — — — — $11.26M — -$0.05 —
Earlier years, FY 2020 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 8, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $62.52M Revenue, change from a year earlier: Q3 2026 −3.9%, Q2 2026 −4.2%, Q1 2026 −10.2%, Q4 2025 −9.0% −9.0% −10.2% −4.2% −3.9%
Net income -$9.39M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m 3.8% by the close of Nov 6
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+8.2% by the close of Aug 7
ended Mar 31, 2026 · filed May 8, 2026 · 38 d ended Jun 30, 2026 · filed Aug 7, 2026 · 38 d ended Sep 30, 2026 · filed Nov 6, 2026 · 37 d window Feb 24 – Mar 11 · projected The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −39.7% after Q3 2023.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks